Raphael Pharmaceutical Inc.
RAPH· OTC
RAPHRaphael Pharmaceutical Inc.
Filed Nov 14, 2022 · 10-Q · 45 days after period end · 0001213900-22-071861
| Metric | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|
| Net Income | -$1.44M | -$416.00K | -$243.00K |
| EPS Diluted | $0.10 | $0.03 | $0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Raphael Pharmaceutical Inc. · CIK 1415397 · Engraved from SEC EDGAR
ended Sep 30, 2022 · filed Nov 14, 2022 · 45 d after period end
